Patent applications published 10 February 2010
Patent applications taken from the weekly European Patents Bulletin
- Pharmaceutical compsn for the treatment of pain
King Pharmaceuticals Research & Development 2150110*
- Substituted 1,3-dioxanes useful as PPAR modulators
Evolva 2150111*
- 2-substituted indole derivatives as calcium channel blockers
Merck 2150112*
- Oxo bridged diazepan orexin receptor antagonists
Merck 2150114*
- Cyclopropyl pyrrolidine orexin receptor antagonists
Merck 2150115*
- Methods and compsns for mitochondrial replacement therapy
The McLean Hospital Corp 2150117*
- Dihydroxybenzoate polymers and uses thereof
Tyrx Pharma 2150119*
- Licorice extract antimicrobial and anti-inflammatory isolates
Tom's of Maine 2150233*
- Stable ophthalmical compsn ketotifen and naphazoline and methods of making same
Bausch & Lomb 2150234*
- Nanoparticle-coated capsule formulation for dermal drug delivery
University of South Australia 2150235*
- Microspheres for treatment of brain tumours
Biocompatibles 2150236*
- Method for the preparation of biocompatible polymeric nanoparticles for drug delivery and nanoparticles prepared thereby
Hannam University Institute for Industry-Academia Cooperation; Korea United Pharm 2150237*
- Method for the production of adsorbates of a rasagiline salt having a water soluble adjuvant
Ratiopharm 2150238*
- Combination with an extended relating pramipexole or a pharmaceutically acceptable salt thereof
Boehringer Ingelheim International 2150239*
- Pharmaceutical compsn exhibiting improved stability comprising ACE inhibitor or pharmaceutically acceptable salt thereof and method for manufacturing thereof
Zaklady Farmaceutyczne Polypharma. 2150240*
- Sustained release microtablets comprising tolterodine tartrate
Specifar 2150241*
- Pharmaceutical compsns of duloxetine
Wockhardt Research Centyre; Jain, Girish; Kandi, Chandrashekhar; Nande, Vishwanath 2150242*
- Compsns and methods for enhancing active agent absorption
Nexus Pharma 2150243*
- Treatment and/or prevention of presbycusis by modulation of metabotropic glutamate receptor 7
House Ear Institute 2150244*
- Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
Schering-Plough 2150245*
- Compsns and methods for treatment of psychiatric disorders
Cambridge Health Alliance 2150246*
- Polyethylene glycol esters and cosmetic and/or dermatological preparations
Symrise 2150247*
- Glutamate receptor antagonists and methods of use
The Johns Hopkins University 2150248*
- Use of benzo-fused heterocycle sulphamide derivatives for the treatment of migraine
Janssen Pharmaceutica 2150249*
- Compsn for suppressing appetite, improving tone and mood, with a natural antidepressant activity and an antiasthenic effect
Medestea Research & Production 2150250*
- Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
Amgen 2150251*
- RAF inhibitors for the treatment of thyroid cancer
Novartis 2150252*
- Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
Sanofi-Aventis 2150253*
- Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
Amicus Therapeutics 2150254*
- Quinaxaline derivatives as P13 kinase inhibitors
SmithKline Beecham 2150255*
- Locally active "soft" antiandrogens
Yale University 2150256*
- Droppirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
Bayer Schering Pharma 2150257*
- improved methods of using phosphoantigens together with interleukin-2 for the treatment of cancer
Innate Pharma 2150258*
- Bioactive and biocompatible polyurethane-butanediol-glycosamino-glycan salt copolymers
Wisconsin Alumni Research Foundation 2150259*
- Compsns and methods for the treatment of heart failure
Phrixus Pharmaceuticals 2150260*
- Kit of parts for the treatment of cancer or infectious diseases
LFB Biotechnologies 2159260*
- Use of Vernonia appendiculata extract for improving the skin status
Bayer Consumer Care 2150262*
- Plant extract and its therapeutic use
Insignion Holdings 2150263*
- Stabilisation of liquid solutions of recombinant protein for frozen storage
Bayer Healthcare 2150264*
- Inhibitors for acetyl-CoA carboxylase for treatment of neuronal hypometabolism
Neuera Pharmaceuticals 2150265*
- Pharmaceutical and/or cosmetic compsn containing an active ingredient which is antioxidant and which activates cell energy
Societe d'Extraction Des Principes Actifs 2150266*
- Pharmaceutical and/or cosmetic compsn containing a cytochrome C-activating active ingredient
Societe d'Extraction Des Principes Actifs 2150267*
- Compsns for prevention of adhesions and other barrier applications
Arch Therapeutics 2150268*
- New cyclic peptide compounds
Astellas Pharma 2150269*
- Methods and compsns for the treatment of cancer
Washington University 2150270*
- Hormone normalisation therapy and uses thereof
The Texas A&M University System; Pregmama 2150271*
- Modified plasminogen activator inhibitor type-1 molecule and methods based thereon
The University of Toledo 2150273*
- Combinations of gene deletions for live attenuated Shigella vaccine strains
The United States of America as represented by the Secretary of the Army, Walter Reed Army Institute of Research 2150274*
- Duck embryonic derived stem cell lines for the production of viral vaccines
Vivalis 2150275*
- Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
Agency for Science, Technology and Research 2150276*
- Adjuvant combination of NKT activator, CD40 antigen, the use through inducing synergistic cellular immunity
Immurx 2150278*
- Novel photosensitiser based on polymer derivatives - photosensitiser conjugates for photodynamic therapy
Korea Institute of Science and Technology 2150278*
- Tenocyte containing bioscaffolds and treatment using the same
The University of Western Australia 2150281*
- Compsns and methods for scaffold formation
Regentis biomaterials 2150282*
- Growth factor modified extracellular matrix material and methods for preparation and use thereof
Cook Biotech 2150283*
- Tissue engineering devices and methods fro luminal organs
Advanced Technologies and Regenerative Medicine 2150284*
- Naphthyl(ethyl) acetamides
Concert Pharmaceuticals 2150525*
- N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
High Point Pharmaceuticals 2150526*
- Anthranilic acid derivative as anticancer agent and process for the preparation thereof
Council of Scientific and Industrial Research (India) 2150527*
- Process for preparation of proguanil hydrochloride
USV 2150528*
- Method of making a lactam in an ionic liquid
DSM IP 2150529*
- Substituted sulphonamide derivatives
Gruenenthal 2150530*
- Novel vanilloid receptor ligands and their use for the production of pharmaceuticals
Gruenenthal 2150531*
- Piperazine compounds for the inhibition of haematopoietic prostaglandin D synthase
Evotec 2150532*
- Process for the preparation of optically active ethenylphenyl alcohols
Lonza 2150533*
- Isoquinolinone derivatives as NK3 antagonists
H Lundbeck 2150534*
- Pyrazole derivatives as P2X7 modulators
Glaxo Group 2150535*
- Process for the production of pyrazoles
Syngenta Participations; Syngenta Ltd 2150536*
- High temperature stable peptide formulation
Acologix 2150537*
- Novel 5-substituted hydantoins
DSM IP 2150538*
- Pyridazinone derivatives
Merck 2150539*
- Method for the production of highly pure 2,4"-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compsns containing the same, and agent formulations containing tolperisone
Sanochemia Pharmazeutika 2150540*